Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in Microsoft Word file format and uses the template that corresponds to the correct article type.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring an Anonymous Review have been followed.

Author Guidelines

Please download the template that corresponds to your article type, and use it to submit your work.

  1. Clinical Trials: Original research on a skin health mechanism, therapy, or procedure. Up to 2500 words and a 250-word structured abstract. Should contain sections for Introduction, Methods, Results, Discussion and Conclusions. Should follow the CONSORT guidelines: http://www.consort-statement.org/. Limited to 5 tables and/or figures. References should be AMA style.
  2. Observational Studies: Original research on a skin health mechanism, disease course, therapy, or procedure. Up to 2000 words and a 250-word structured abstract. Should contain sections for Introduction, Methods, Results, Conclusions. Should follow the STROBE guidelines https://www.equator-network.org/reporting-guidelines/strobe/. Limited to 4 tables and/or figures. References should be AMA style.
  3. Case Series: Original collections of procedures, disease presentation, and/or treatments. Up to 1500 words and a 250-word structured abstract. Should contain sections for Introduction, Case, Results, Conclusions. Should follow the CARE guidelines: https://www.care-statement.org/. Limited to 2 tables and/or figures. References should be AMA style and are limited to 10.
  4. Reviews: Original systematic or narrative assessments of diseases, treatments, procedures in skin health and disease. Up to 2500 words and a 250-word unstructured abstract. Should contain sections for Introduction, Methods (if systematic), Conclusions. Systematic reviews should follow the PRISMA guidelines: http://www.prisma-statement.org/. Limited to 3 tables and/or figures. References should be AMA style.
  5. Case and Reviews: Open to original drug reactions, rare disease presentations, and treatments where a substantial summary of the existing literature is conducted. Note: Case reports with only a cursory review of the literature will not be reviewed unless it fits into a case series or innovative therapeutic approach. Up to 2000 words and a 250-word unstructured abstract. Should contain sections for Introduction, Case(s), Discussion, and Conclusions. Systematic reviews should follow the PRISMA guidelines: http://www.prisma-statement.org/. Limited to 3 tables and/or figures. References should be AMA style.
  6. Innovative Therapeutic Approaches: Open to brief case reports or case series that detail an existing problem in skin health and disease, and a novel and scalable solution to that problem. Support of novelty is required. No abstract. Up to 750 words. References should be AMA style and are limited to 5.
  7. Clinical Trial Protocols: This section is open to investigators who want to publish the protocol and methods for an ongoing clinical trial and who must be registered with the national clinical trials register (ClinicalTrials.Gov) and include their registration number. A structured abstract is required, and the manuscript may be up to 2500 words. The manuscript should include sections for:  Introduction, Methods, Preliminary Results (if any), and Discussion. Under Methods, subheaders should include: Research Hypothesis, Primary Objective, Secondary Objectives, Study Design, Recruitment, Eligibility, Randomization, Study Interventions, Outcome Measures, Sample Size Calculations, and Statistical Analysis.  References should be AMA style and are limited to 25. 
  8. Letters to the Editor: A response to published document or an opinion piece on a skin health topic that is important and current. Limited to 500 words and up to 5 AMA style references.
  9. How I Treat/Perform***: This is an invitation only article type for leaders in the field to detail treatment strategies for challenging medical and surgical cases. This type is limited to 750 words and up to 10 AMA style references.
  10. Commentary and Editorials: This is an invitation only article type for reviewers and leaders in the field of skin health and disease to draw attention and comment on potentially impactful articles published in this journal. This article type is limited to 500 words and up to 5 AMA style references.

Copyright Notice

This Author Agreement for Academic Dermatology ("Agreement") is entered into by and between The Ohio State University, on behalf of its University Libraries ("Publisher") and the author ("Author").

For good and valuable consideration, Publisher and Author agree as follows:

1. Author hereby grants to Publisher the right to publish, reproduce, distribute, translate, transmit and display his/her submitted work and an abstract thereof ("Work") in the Academic Dermatology in whole or in part and in all formats and all media. Author also hereby grants to Publisher the right for Publisher to enter into agreements with third parties that grant such third parties any or all of the rights that Author has granted to Publisher herein. The aforementioned rights may include the rights necessary to index and abstract the Work. The Author agrees that any subsequent publication of the Work will credit Academic Dermatology as the site of first publication and provide a link to Academic Dermatology website. This Agreement is subject to the terms and expectations outlined on Publisher's website (http://go.osu.edu/publishing-services).

2. Author represents and war­rants that: (1) they are the creator and rights holder of the Work; (2) Publisher's exercise of the rights granted to Publisher herein will not infringe or violate any copyright or any other right of a third party; (3) if the Work contains any third party content, they have obtained the unrestricted permission of the copyright owner or that use of third party material is allowed because the material is in the public domain or an appropriate fair use analysis has been performed and there is a reasonable belief that use is permitted and (4) the Work contains nothing libelous or otherwise unlawful. Author hereby agrees to indemnify and hold harmless Publisher and its trustees, officers, employees, agents, and subgrantees from all claims related to Publisher's exercise of the rights granted to Publisher herein or related to the subject matter covered in Author's representations and warranties.

Academic Dermatology is published under a Creative Commons Attribution 4.0 International license, to allow for certain types of reuse without permission. By submitting this agreement, the Author agrees to apply a CC BY 4.0 license to the Work upon publication.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.